US Patent Issued to Celex Oncology Innovations on April 21 for "Treatment of cancer and inhibition of metastasis" (Swiss, British Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,390, issued on April 21, was assigned to Celex Oncology Innovations Ltd. (London).

"Treatment of cancer and inhibition of metastasis" was invented by Carsten Faltum (Vitznau, Switzerland), Leif Helth Jensen (Vitznau, Switzerland) and Mustafa Djamgoz (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds and methods are disclosed for reducing or preventing metastatic behaviour in VGSC expressing cancer by the effect of at least reducing the persistent part of the voltage gated sodium channel current without eliminating the transient part, thereby inhibiting the metastatic and invasive growth of malignant cells in a cancer patient."

The pa...